A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy

NCT01136655 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: 80/2.25 μg Symbicort pMDI
DRUG: 80/4.5 μg Symbicort pMDI
DRUG: Foradil Aerolizer 12 μg
DRUG: 40 μg budesonide HFA pMDI
DRUG: placebo HFA pMDI

Sponsor

AstraZeneca